Industry News

Oyster Point Pharma Reveals Restructuring Plan to Reduce Expenses

Oyster Point Pharma announced it will implement an operating expense streamlining plan that will include a reduction of employee and non-employee expenses across the organization.

Oyster Point Pharma Reveals Restructuring Plan to Reduce Expenses
July 04, 2022
Efficacy of Notal Vision Home OCT Proven by a Series of Scientific and Clinical Work

Notal Vision reported that scientific and clinical publications and presentations demonstrate the feasibility and efficacy of their patient-operated, home-based optical coherence tomography (OCT) device.

Efficacy of Notal Vision Home OCT Proven by a Series of Scientific and Clinical Work
July 01, 2022
BRIM Biotechnology Enters OTC Trading in Taiwan

BRIM Biotechnology has entered OTC trading in Taiwan on June 23, 2022. Established in 2013, BRIM is a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases.

BRIM Biotechnology Enters OTC Trading in Taiwan
June 29, 2022
Schneider Unveils Modulo One, the First Fully Automated Optical Lab, at Digicon Conference

Optical laboratory owners and operators from around the globe gathered last week at Digicon 2022, a conference sponsored by Schneider Optical Machines that served as a springboard to launch Modulo One, the company’s fully automated platform.

Schneider Unveils Modulo One, the First Fully Automated Optical Lab, at Digicon Conference
June 28, 2022
American Academy of Optometry Foundation Announces Inaugural BRIGHT IDEAS Pitch Competition

The American Academy of Optometry Foundation is a nonprofit, philanthropic organization that develops and provides financial support for optometric research and education in vision and eye health to improve clinical care.

American Academy of Optometry Foundation Announces Inaugural BRIGHT IDEAS Pitch Competition
June 23, 2022
Lensar Receives U.S. FDA Clearance of ALLY Adaptive Cataract Treatment System

ORLANDO, Fla.—Lensar, Inc. (NASDAQ: LNSR), based here, announced that it has received U.S. Food and Drug Administration 510(k) clearance for its next-generation ALLY Adaptive Cataract Treatment System.

Lensar Receives U.S. FDA Clearance of ALLY Adaptive Cataract Treatment System
June 20, 2022
Nacuity Pharmaceuticals Receives $16.5 Million Series B Financing to Support its Clinical Trials

Nacuity Pharmaceuticals announced the closing of a $16.5 million Series B financing led by Foundation Fighting Blindness and its venture arm RD Fund. Additional existing investors also participated in the round.

Nacuity Pharmaceuticals Receives $16.5 Million Series B Financing to Support its Clinical Trials
June 16, 2022
Vyluma and Laboratoires Théa Sign Licensing Agreement for Commercialization of Childhood Myopia Drug

Vyluma and Laboratoires Théa announced that they have recently entered into an exclusive licensing agreement for the registration and commercialization of NVK002 in Canada, Mexico, and select South American Countries.

Vyluma and Laboratoires Théa Sign Licensing Agreement for Commercialization of Childhood Myopia Drug
June 15, 2022
Samsara and Lansheng Medical Collaborate to Commercialize the SING IMT in China

Samsara Vision has formed a collaboration with Lansheng Medical “MyVision,” to develop a clinical and commercial organization to support Samsara Vision’s SING IMT (Smaller-Incision New-Generation Implantable Miniature Telescope) in China.

Samsara and Lansheng Medical Collaborate to Commercialize the SING IMT in China
June 13, 2022
Rayner Acquires Stake in Surgical Instrument Belgian Manufacturer Hasa Optix

Rayner announced that it has entered into a commercial partnership and concurrently acquired a stake in Hasa Optix, a Brussels-based manufacturer of single use ophthalmic surgical instruments and instrument sets.

Rayner Acquires Stake in Surgical Instrument Belgian Manufacturer Hasa Optix
June 09, 2022
Daha fazla